Ventura, CA, United States of America

Andrew Cosbie

This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Amgen Inc.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Cosbie. Retrieved from https://idiyas.com/inventor/andrew-cosbie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Andrew Cosbie

Introduction

Andrew Cosbie is a notable inventor based in Ventura, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of complex compounds. With a total of 3 patents to his name, Cosbie continues to push the boundaries of innovation in his industry.

Latest Patents

One of Andrew Cosbie's latest patents is the synthesis of omecamtiv mecarbil. This patent provides a detailed synthesis for omecamtiv mecarbil dihydrochloride hydrate and various intermediates. His work in this area showcases his expertise and commitment to advancing medical science.

Career Highlights

Cosbie is currently employed at Amgen Inc., a leading biotechnology company. His role at Amgen allows him to collaborate with other talented professionals in the field. His contributions have been instrumental in the development of new therapeutic solutions.

Collaborations

Some of Andrew Cosbie's coworkers include Sebastien Caille and Kyle Quasdorf. Their collaborative efforts contribute to the innovative environment at Amgen, fostering advancements in biotechnology.

Conclusion

Andrew Cosbie is a dedicated inventor whose work in the synthesis of pharmaceutical compounds is making a significant impact. His patents and collaborations reflect his commitment to innovation in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…